Executive Appointment, J.P. Morgan Healthcare Conference Presentation Schedules, and Q4 2013 Results Schedule - Research Report

    Executive Appointment, J.P. Morgan Healthcare Conference Presentation
    Schedules, and Q4 2013 Results Schedule - Research Report on McKesson,
             Omnicare, HealthSouth, Kindred Healthcare, and Geron

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

NEW YORK, January 13, 2014

NEW YORK, January 13, 2014 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting McKesson
Corporation (NYSE: MCK), Omnicare, Inc. (NYSE: OCR), HealthSouth Corporation
(NYSE: HLS), Kindred Healthcare, Inc. (NYSE: KND), and Geron Corporation
(NASDAQ: GERN). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings - via the
links below.

McKesson Corporation Research Report 

On January 6, 2014, McKesson Corporation's subsidiary McKesson Specialty
Health (McKesson Specialty) and The US Oncology Network jointly announced the
appointment of Jeffrey Kao as Chief Information Officer and Senior Vice
President of Information & Technology Services. According to the Company, in
his new role, Kao will be responsible for overseeing all support technologies
for practices in The US Oncology Network, overseeing the internal technology
infrastructure, and delivering innovative, advanced technology solutions to
support the physicians and customers of McKesson Specialty. "Jeff has a proven
track record in planning, building and deploying industry-leading technologies
- both internally and externally," said Marc Owen, President of McKesson
Specialty. "We believe that Jeff is the right person to guide our organization
to the next stage of healthcare technology innovation, and help our customers
and The US Oncology Network physicians achieve their clinical and operational
goals in a safe, efficient manner." The Full Research Report on McKesson
Corporation - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/a057_MCK

--

Omnicare, Inc. Research Report 

On January 7, 2014, Omnicare, Inc. (Omnicare) announced its participation at
the 32nds Annual J.P. Morgan Healthcare Conference in San Francisco,
California. The Company informed that it is scheduled to make a presentation
at the aforesaid conference on January 14, 2014 at 3:00 p.m. PT / 6:00 p.m.
ET. According to the Company, the presentation will be broadcast live over the
Internet and can be accessed from Omnicare's Investor Relations website. The
Full Research Report on Omnicare, Inc. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at:

http://www.analystscorner.com/r/full_research_report/ef9e_OCR

--

HealthSouth Corporation Research Report

On January 8, 2014, HealthSouth Corporation (HealthSouth) announced that it
will report its Q4 2013 results on February 19, 2014, after the market closes.
The Company informed that it will host an investor conference call on the
following day, February 20, 2014, at 9:00 a.m. ET, to discuss the results.
HealthSouth stated that the conference call will also be webcast live via its
website, wherein a replay of the same will be available, beginning
approximately two hours after the completion of the call, from February 20,
2014 until March 6, 2014. The Full Research Report on HealthSouth Corporation
- including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/9080_HLS

--

Kindred Healthcare, Inc. Research Report

On January 8, 2014, Kindred Healthcare, Inc. (Kindred Healthcare) announced
that it will be presenting at the 32^nd Annual J.P. Morgan Healthcare
Conference in San Francisco on January 15, 2014. The Company informed that its
CEO Paul J. Diaz is scheduled to make a presentation on the aforesaid date at
9:30 a.m. PT / 12:30 p.m. ET. Kindred Healthcare stated that an audio webcast
of the presentation and any written materials accompanying the presentation
can be accessed at the Company's website. The Full Research Report on Kindred
Healthcare, Inc. - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/ab58_KND

--

Geron Corporation Research Report

On January 8, 2014, Geron Corporation (Geron) announced that it will be
participating at the 32^nd Annual J.P. Morgan Healthcare Conference in San
Francisco. According to the Company, John Scarlett, M.D., President and CEO of
Geron, will present an overview of the Company, including plans for further
development of its telomerase inhibitor, imetelstat, in myelofibrosis, on
January 15, 2014 at 1:30 p.m. PT. The Full Research Report on Geron
Corporation - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/1ca9_GERN

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Nidhi Vatsal, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

SOURCE Analysts' Corner

Contact: CONTACT PERSON: Joe Thomas CONTACT PHONE: +1-310-496-8071 (North
America)
 
Press spacebar to pause and continue. Press esc to stop.